r crizotinib, c met hepatocyte growth factor receptor tyrosine kinase inhibitor pf 02341066, c met hgfr tyrosine kinase inhibitor pf 02341066
Crizotinib is used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic-lymphoma kinase (ALK)-positive as detected by a ...